Eveline P. van Poelgeest

Acute Kidney Injury During Therapy With an Antisense Oligonucleotide Directed Against PCSK9

Eveline P. van Poelgeest, Reinout M. Swart, Michiel G.H. Betjes et al. · American Journal of Kidney Diseases · 2013 · 88 citations

Urology, Medicine, Kidney Failure +9

Antisense‐mediated reduction of proprotein convertase subtilisin/kexin type 9 (PCSK9): a first‐in‐human randomized, placebo‐controlled trial

Eveline P. van Poelgeest, Michael R. Hodges, Matthijs Moerland et al. · British Journal of Clinical Pharmacology · 2015 · 87 citations · Full text

Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS

Emmanuel Monnet, G Lapeyre, Eveline P. van Poelgeest et al. · Clinical Pharmacology & Therapeutics · 2016 · 75 citations

Bramwell-Hill modeling for local aortic pulse wave velocity estimation: a validation study with velocity-encoded cardiovascular magnetic resonance and invasive pressure assessment

Jos J.M. Westenberg, Eveline P. van Poelgeest, Paul Steendijk et al. · Journal of Cardiovascular Magnetic Resonance · 2012 · 71 citations · Full text

Characterization of inflammation and immune cell modulation induced by low-dose LPS administration to healthy volunteers

Marlous R. Dillingh, Eveline P. van Poelgeest, Karen E. Malone et al. · Journal of Inflammation · 2014 · 55 citations · Full text